PlainRecalls
FDA Drug Moderate Class II Terminated

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Reported: February 12, 2025 Initiated: January 24, 2025 #D-0217-2025

Product Description

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Reason for Recall

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
247 blister packs
Distribution
FL
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.. Recalled by RemedyRepack Inc.. Units affected: 247 blister packs.
Why was this product recalled?
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2025. Severity: Moderate. Recall number: D-0217-2025.